来那度胺
化学
小脑
组合化学
体外
衍生化
立体化学
亚甲基
多发性骨髓瘤
生物化学
药物化学
有机化学
高效液相色谱法
医学
基因
泛素连接酶
泛素
免疫学
作者
Donghuai Xiao,Yu‐jie Wang,Hanlin Wang,Yubo Zhou,Jia Xuan Li,Wei Ping Lu,Jiyu Jin
标识
DOI:10.1002/ardp.201900376
摘要
Abstract Lenalidomide is a cereblon modulator known for its antitumor, anti‐inflammatory, and immunomodulatory properties in clinical applications. Recently, some reported lenalidomide analogs could exhibit a significant bioactivity through various modifications in the isoindolinone ring. In this study, we designed and synthesized a series of novel lenalidomide analogs on the basis of the installation of a methylene chain at the C‐4 position of isoindolinone via the Suzuki cross‐coupling reaction. These new compounds were further evaluated for their in vitro antiproliferative activities against two tumor cell lines (MM.1S and Mino). Specifically, compound 4c displayed the strongest antiproliferative activity against the MM.1S (IC50 = 0.27 ± 0.03 μM) and Mino (IC50 = 5.65 ± 0.58 μM) tumor cell lines. In summary, we have developed a new synthetic strategy for C‐4 derivatization of lenalidomide, providing a bioactive scaffold that could be used to discover further potential antitumor lead compounds in pharmaceutical research.
科研通智能强力驱动
Strongly Powered by AbleSci AI